» Articles » PMID: 21329880

Identification of an MRNP Complex Regulating Tumorigenesis at the Translational Elongation Step

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2011 Feb 19
PMID 21329880
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Transcript-selective translational regulation of epithelial-mesenchymal transition (EMT) by transforming growth factor-β (TGF-β) is directed by the hnRNP E1-containing TGF-β-activated-translational (BAT) mRNP complex. Herein, eukaryotic elongation factor-1 A1 (eEF1A1) is identified as an integral component of the BAT complex. Translational silencing of Dab2 and ILEI, two EMT transcripts, is mediated by the binding of hnRNP E1 and eEF1A1 to their 3'UTR BAT element, whereby hnRNP E1 stalls translational elongation by inhibiting the release of eEF1A1 from the ribosomal A site. TGF-β-mediated hnRNP E1 phosphorylation, through Akt2, disrupts the BAT complex, thereby restoring translation of target EMT transcripts. Attenuation of hnRNP E1 expression in two noninvasive breast epithelial cells (NMuMG and MCF-7) not only induced EMT but also enabled cells to form metastatic lesions in vivo. Thus, translational regulation by TGF-β at the elongation stage represents a critical checkpoint coordinating the expression of EMT transcripts required during development and in tumorigenesis and metastatic progression.

Citing Articles

Regulation of HNRNP family by post-translational modifications in cancer.

Li B, Wen M, Gao F, Wang Y, Wei G, Duan Y Cell Death Discov. 2024; 10(1):427.

PMID: 39366930 PMC: 11452504. DOI: 10.1038/s41420-024-02198-7.


Identification of RNA structures and their roles in RNA functions.

Cao X, Zhang Y, Ding Y, Wan Y Nat Rev Mol Cell Biol. 2024; 25(10):784-801.

PMID: 38926530 DOI: 10.1038/s41580-024-00748-6.


Alternative splicing in EMT and TGF-β signaling during cancer progression.

Zhang Y, Stuelten C Semin Cancer Biol. 2024; 101:1-11.

PMID: 38614376 PMC: 11180579. DOI: 10.1016/j.semcancer.2024.04.001.


PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.

Streitfeld W, Dalton A, Howley B, Howe P Cancer Biol Ther. 2023; 24(1):2271638.

PMID: 37927213 PMC: 10629429. DOI: 10.1080/15384047.2023.2271638.


Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins.

Feng Y, Zhu S, Liu T, Zhi G, Shao B, Liu J Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631029 PMC: 10458901. DOI: 10.3390/ph16081114.


References
1.
Bierie B, Moses H . TGF-beta and cancer. Cytokine Growth Factor Rev. 2005; 17(1-2):29-40. DOI: 10.1016/j.cytogfr.2005.09.006. View

2.
Monnier A, Belle R, Morales J, Cormier P, Boulben S, Mulner-Lorillon O . Evidence for regulation of protein synthesis at the elongation step by CDK1/cyclin B phosphorylation. Nucleic Acids Res. 2001; 29(7):1453-7. PMC: 31266. DOI: 10.1093/nar/29.7.1453. View

3.
Gershtein E, Shatskaya V, Ermilova V, Kushlinsky N, Krasilnikov M . Phospatidylinositol 3-kinase expression in human breast cancer. Clin Chim Acta. 1999; 287(1-2):59-67. DOI: 10.1016/s0009-8981(99)00118-7. View

4.
Wolf H, Chinali G, Parmeggiani A . Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes. Eur J Biochem. 1977; 75(1):67-75. DOI: 10.1111/j.1432-1033.1977.tb11504.x. View

5.
Clark I, Wyckoff D, Gavis E . Synthesis of the posterior determinant Nanos is spatially restricted by a novel cotranslational regulatory mechanism. Curr Biol. 2000; 10(20):1311-4. DOI: 10.1016/s0960-9822(00)00754-5. View